Banque Pictet & Cie’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Banque Pictet & Cie’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,090	Closed	-$461K	–	350
2015 Q3	$461K	Sell	10,090 -1,700	-14%	-$95K	0.01%	266
2015 Q2	$688K	Hold	11,790	–	–	0.05%	179
2015 Q1	$650K	Hold	11,790	–	–	0.02%	295
2014 Q4	$592K	Hold	11,790	–	–	0.02%	297
2014 Q3	$545K	Hold	11,790	–	–	0.01%	284
2014 Q2	$515K	Hold	11,790	–	–	0.01%	277
2014 Q1	$491K	Buy	+11,790	New	+$504K	0.01%	269

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Banque Pictet & Cie's PBE Position: Q4 2015 in Review

Banque Pictet & Cie sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2015, closing a stake of 10,090 shares — an estimated $461K sold.

Banque Pictet & Cie first reported a position in PBE in Q1 2014 and held it in 7 quarters. The position peaked at $688K in Q2 2015. 86 funds tracked by Wall St. Rank hold PBE as of Q4 2015.

Banque Pictet & Cie reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2015 after selling out during the quarter.
Banque Pictet & Cie sold 10,090 Invesco Biotechnology & Genome ETF shares in Q4 2015, an estimated $461K.
Banque Pictet & Cie first reported a position in Invesco Biotechnology & Genome ETF in Q1 2014 and held it in 7 quarters.
Banque Pictet & Cie's Invesco Biotechnology & Genome ETF position peaked at $688K in Q2 2015.
86 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2015.

Based on Banque Pictet & Cie's 13F filing for Q4 2015, filed 3 Feb 2016.